Kiniksa Pharmaceuticals Intern - COM (KNSA)

Historical Holders from Q2 2018 to Q1 2025

Symbol
KNSA on Nasdaq
CUSIP
G5269C101
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
128K
Holdings value
$2.53M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
2
Number of buys
1
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 77.7K $1.73M -$452K $22.21 1
2024 Q4 128K $2.53M +$10.9K $19.78 2
2024 Q3 128K $3.19M +$1.75M $24.99 2
2024 Q2 66.8K $1.25M -$765M $18.66 5
2024 Q1 38.9M $768M +$104M $19.73 152
2023 Q4 34.2M $600M -$47M $17.54 141
2023 Q3 34.9M $606M +$53.6M $17.37 133
2023 Q2 31.8M $448M +$4.82M $14.08 124
2023 Q1 31.5M $339M +$13.1M $10.76 129
2022 Q4 29.8M $446M +$8.59M $14.98 122
2022 Q3 29.9M $383M +$7.9M $12.84 101
2022 Q2 29.3M $285M -$8.49M $9.69 86
2022 Q1 30.4M $302M +$13.4M $9.94 89
2021 Q4 29.4M $346M +$3.16M $11.77 97
2021 Q3 29.1M $332M -$3.1M $11.39 97
2021 Q2 28.8M $401M -$17.1M $13.93 98
2021 Q1 29M $537M -$12.1M $18.51 102
2020 Q4 29.8M $526M +$25.1M $17.67 107
2020 Q3 28.3M $434M +$112M $15.32 99
2020 Q2 21.1M $538M +$101M $25.48 92
2020 Q1 17.7M $274M +$44.3M $15.48 72
2019 Q4 15.1M $167M -$137K $11.06 57
2019 Q3 15.5M $132M -$16.9M $8.51 50
2019 Q2 16.5M $224M +$1.37M $13.54 58
2019 Q1 16.3M $294M +$33.9M $18.06 54
2018 Q4 13.7M $385M -$47.9M $28.09 51
2018 Q3 14.4M $363M -$79.1M $25.50 54
2018 Q2 17.3M $298M +$298M $17.35 41